Solara Active Pharma Sciences Limited announced the appointment of S. Hariharan as Chief Financial Officer of the company, effective March 9, 2022. He succeeds Subhash Chand Anand, who has resigned from the role of CFO of the company.
According to the company’s exchange filing, “the Board of Directors of the Company, pursuant to the recommendation by the Nomination and Remuneration Committee and Audit Committee, approved the appointment of Mr. S. Hariharan as Executive Director and Chief Financial Officer (CFO) of the Company.”
Hariharan is a Cost Accountant with rich and varied experience of more than 30 years in field of Corporate Finance, Accounts and Strategic planning. He played a very important role in the merger process of Shasun with Strides during 2014 and 2015. Also in demerger process of Strides, SeQuent and Solara during 2017 and 2018. He has rich experience in the fields of Finance, Accounts, Secretarial, Taxation, Legal and Information Technology functions. He has extensive experience in Mergers and Acquisitions.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.